Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries : part A: pathophysiology, prevalence and cardiovascular risk estimation
Clinical management of hypertension in patients with autoimmune rheumatic diseases (ARDs) is challenging. Firstly, the impact on blood pressure (BP) of several antirheumatic drugs varies and the available evidence points towards a wide range of effects. Secondly, management of hypertension in terms...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
August 2026
|
| In: |
Journal of hypertension
Year: 2026, Volume: 44, Fascicolo: 8, Pages: 1295-1307 |
| ISSN: | 1473-5598 |
| DOI: | 10.1097/HJH.0000000000004332 |
| Accesso online: | Verlag, kostenfrei, Volltext: https://doi.org/10.1097/HJH.0000000000004332 Verlag, kostenfrei, Volltext: https://www.ovid.com/jnls/jhypertension/fulltext/10.1097/hjh.0000000000004347~hypertension-in-autoimmune-rheumatic-diseases-a-position 
|
| Note sull'autore: | Eugenia Gkaliagkousi, Antonios Lazaridis, Carolina de Ciuceis, Michael Doumas, Krzysztof Narkiewicz, Claudia Agabiti-Rosei, Panagiota Anyfanti, Anastasia Malliora, Konstantinos Stellos, Nikolaos Vlachogiannis, Maria S. Stoenoiu, Konstantinos Stavropoulos, Theodoros Dimitroulas, Georgios Mavraganis, Kimon Stamatelopoulos, Dimitrios Terentes-Printzios, Ignatios Ikonomidis, Francisco Rios, Barbara Anna Kutryb-Zając, Francesco Paneni, Alessandro Mengozzi, Ryszard Nosalski, Georgios Georgiopoulos, George Pavlidis, Simon Tual-Chalot, Livia Camargo, Federica Cappelli, Edyta Dąbrowska, Fosca Quarti-Trevano, Marcin Hellmann, Stefano Masi, Augusto Montezano, Pawel Winklewski, Jacek Wolf, Sarah Costantino, Ines Drenjančević, Stefano Taddei, Tomasz Guzik, Reinhold Kreutz, Christian Delles, Rhian Touyz, Alexandre Persua, Thomas Weber, Margus Viigimaa, Guido Grassi, Agostino Virdis |
| Riassunto: | Clinical management of hypertension in patients with autoimmune rheumatic diseases (ARDs) is challenging. Firstly, the impact on blood pressure (BP) of several antirheumatic drugs varies and the available evidence points towards a wide range of effects. Secondly, management of hypertension in terms of diagnosis, BP thresholds and therapeutic targets currently follows the general recommendations, even though patients with ARDs present a markedly adverse cardiovascular profile. Thirdly, lifestyle interventions in terms of non-pharmaceutical management follow the general recommendations. Notably, it has been shown that they can improve autoimmune disease-specific endpoints, however, their intimate effect on BP has not been fully explored. Finally, the choice of anti-hypertensive medication currently complies with the general antihypertensive therapy recommendations, in the absence of appropriately designed studies in these populations. This review aims to summarize the impact of antirheumatic drugs on BP and present the available data regarding clinical management of hypertension in patients with ARDs. |
|---|---|
| Descrizione del documento: | Gesehen am 21.07.2026 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1473-5598 |
| DOI: | 10.1097/HJH.0000000000004332 |